CHEMICAL BANK - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHEMICAL BANK ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2019$1,003,000
-5.0%
10,9870.0%0.11%
-4.2%
Q1 2019$1,056,000
-3.0%
10,987
-13.4%
0.12%
-11.9%
Q4 2018$1,089,000
+0.9%
12,690
+1.3%
0.14%
+20.5%
Q3 2018$1,079,000
+24.6%
12,522
+9.3%
0.11%
+20.4%
Q2 2018$866,000
-2.6%
11,455
+4.2%
0.09%
-4.1%
Q1 2018$889,000
-3.7%
10,9980.0%0.10%
-2.0%
Q4 2017$923,000
-2.2%
10,9980.0%0.10%
-5.7%
Q3 2017$944,000
+2.6%
10,998
-0.2%
0.10%
+5.0%
Q2 2017$920,000
+12.5%
11,018
+0.1%
0.10%
+9.9%
Q1 2017$818,000
+3.7%
11,004
+1.6%
0.09%
+1.1%
Q4 2016$789,000
-6.2%
10,830
+1.7%
0.09%
-20.4%
Q3 2016$841,000
-4.3%
10,6500.0%0.11%
-7.4%
Q2 2016$879,000
+13.0%
10,650
-0.9%
0.12%
+11.9%
Q1 2016$778,000
-25.6%
10,744
-11.5%
0.11%
-25.3%
Q4 2015$1,045,000
-16.7%
12,144
-10.9%
0.15%
-19.3%
Q3 2015$1,254,000
-6.5%
13,6350.0%0.18%
+1.7%
Q2 2015$1,341,000
-0.3%
13,6350.0%0.18%
+1.1%
Q1 2015$1,345,000
+12.2%
13,635
+5.4%
0.18%
+12.8%
Q4 2014$1,199,000
+199.8%
12,935
+204.4%
0.16%
+126.1%
Q3 2014$400,000
+4.2%
4,2500.0%0.07%
+6.2%
Q2 2014$384,000
+6.1%
4,2500.0%0.06%0.0%
Q1 2014$362,000
+5.8%
4,2500.0%0.06%
+6.6%
Q4 2013$342,000
+4.9%
4,2500.0%0.06%
-3.2%
Q3 2013$326,000
+6.9%
4,250
-1.6%
0.06%
+5.0%
Q2 2013$305,0004,3170.06%
Other shareholders
NOVARTIS A G shareholders Q1 2019
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders